Literature DB >> 21357937

Atorvastatin reduces high glucose toxicity in rat peritoneal mesothelial cells.

Blanca Carrión1, Francisco C Pérez-Martínez, Silvia Monteagudo, María D Pérez-Carrión, Carmen Gómez-Roldán, Valentín Ceña, Juan Pérez-Martínez.   

Abstract

OBJECTIVE: Continuous exposure of the peritoneal membrane to high glucose dialysis solutions can produce functional alterations in this membrane. We studied the toxic effects of high glucose (50 mmol/L and 83 mmol/L) and its reversal by atorvastatin (0.5 - 5 μmol/L) on cultures of rat peritoneal mesothelial cells (PMCs).
METHODS: Rat PMCs were harvested from the peritonea of male Sprague-Dawley rats and grown in M199 medium supplemented with 10% fetal bovine serum. The effects of high glucose (50 mmol/L and 83 mmol/L) on levels of reactive oxygen species (ROS), on caspase 3 activity, and on phospho-p38 mitogen-activated protein kinase (MAPK) in the cultures were evaluated.
RESULTS: Exposure to high glucose (for 4, 8, and 24 hours) increased intracellular levels of ROS and phospho-p38 MAPK (indices of cellular toxicity). Atorvastatin blocked these toxic effects of high glucose, being more effective against 50 mmol/L glucose (protective effects were observed above 0.5 μmol/L) than against 83 mmol/L (protective effects were observed above 2.5 μmol/L). Atorvastatin was also able to prevent glucose-induced increase in caspase 3 activity.
CONCLUSIONS: The present study shows that high glucose may promote oxidative stress and may activate apoptotic pathways in rat PMCs. These toxic effects could be reversed by atorvastatin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357937     DOI: 10.3747/pdi.2010.00164

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  3 in total

1.  Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway.

Authors:  Li Zhang; Jia Liu; Yanchun Liu; Yaguang Xu; Xiufen Zhao; Jun Qian; Bin Sun; Changying Xing
Journal:  Clin Exp Nephrol       Date:  2014-06-20       Impact factor: 2.801

2.  Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats.

Authors:  Juan Pérez-Martínez; Francisco C Pérez-Martínez; Blanca Carrión; Jesús Masiá; Agustín Ortega; Esther Simarro; Syong H Nam-Cha; Valentín Ceña
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 3.  IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

Authors:  Vanessa Marchant; Antonio Tejera-Muñoz; Laura Marquez-Expósito; Sandra Rayego-Mateos; Raul R Rodrigues-Diez; Lucia Tejedor; Laura Santos-Sanchez; Jesús Egido; Alberto Ortiz; Jose M Valdivielso; Donald J Fraser; Manuel López-Cabrera; Rafael Selgas; Marta Ruiz-Ortega
Journal:  Biomolecules       Date:  2020-09-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.